Overview
Nadia Mitchell practices in Christchurch, New Zealand. Ms. Mitchell is rated as a Distinguished expert by MediFind in the treatment of CLN5 Disease. Her top areas of expertise are CLN2 Disease, CLN5 Disease, CLN3 Disease, and CLN1 Disease.
Her clinical research consists of co-authoring 27 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 20 articles in the study of CLN5 Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Batten DiseaseMs. Mitchell isDistinguished. Learn about Batten Disease.
- CLN1 DiseaseMs. Mitchell isDistinguished. Learn about CLN1 Disease.
- CLN2 DiseaseMs. Mitchell isDistinguished. Learn about CLN2 Disease.
- CLN3 DiseaseMs. Mitchell isDistinguished. Learn about CLN3 Disease.
- CLN4 DiseaseMs. Mitchell isDistinguished. Learn about CLN4 Disease.
- CLN5 DiseaseMs. Mitchell isDistinguished. Learn about CLN5 Disease.
- Experienced
- Late-Onset Retinal DegenerationMs. Mitchell isExperienced. Learn about Late-Onset Retinal Degeneration.
- Mucopolysaccharidoses (MPS)Ms. Mitchell isExperienced. Learn about Mucopolysaccharidoses (MPS).
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)